Dr. Gerald Maguire, a clinical psychiatrist at the University of California, Riverside, has long studied stuttering, a speech disorder affecting roughly 80 million people worldwide. His personal experience drove him to medical school, where he explored the neurological underpinnings of the condition, marked by repetitions, prolonged sounds, and silent blocks. For years, many experts dismissed stuttering as a behavioral quirk or a childhood phase, leaving the condition understudied. "I'm always shocked by how little physicians know about stuttering," Dr. Maguire said.
To address the knowledge gap, Dr. Maguire founded the Stuttering Treatment and Research Society, a nonprofit advancing neuroscience research and therapy. This year, he convened over 30 international researchers, including psychiatrists, neuroscientists, and people who stutter, to develop the first consensus medical guidelines on stuttering, published in August in Psychiatric Times. Nearly all panelists agreed stuttering should be classified as a brain-based disorder linked to conditions like A.D.H.D. and Tourette syndrome.
Despite scientific progress, 90% of participants rated current treatment as only "fair" or "poor." Traditional therapy focuses on speaking exercises, which many experts say lag behind recent discoveries. Dr. Maguire is testing psychiatric medications, while other scientists explore options ranging from vitamin supplements to psychedelic mushrooms. Still, Eric Jackson, a researcher at New York University who stutters, noted that decades of science have done little to improve real-world speech therapy options.
Source: New York Times Top Stories · Summarized by HeadlinesBriefing